Evidence map›Paper›PMID 31145099›Full record

ArticleJCI insight2019

Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection.

Anna Zychlinsky Scharff, Matthieu Rousseau, Livia Lacerda Mariano, Tracy Canton, Camila Rosat Consiglio, Matthew L Albert, Magnus Fontes, Darragh Duffy, Molly A Ingersoll

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. IL-17B protects against uropathogenicMicrobiology spectrum · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. A simpleFEMS microbes · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Anna Zychlinsky ScharffDepartment of Immunology, Institut Pasteur, Paris, France.
Matthieu RousseauDepartment of Immunology, Institut Pasteur, Paris, France.
Livia Lacerda MarianoDepartment of Immunology, Institut Pasteur, Paris, France.
Tracy CantonDepartment of Immunology, Institut Pasteur, Paris, France.
Camila Rosat ConsiglioDepartment of Immunology, Institut Pasteur, Paris, France.
Matthew L AlbertDepartment of Immunology, Institut Pasteur, Paris, France.
Magnus FontesInternational Group for Data Analysis, Institut Pasteur, Paris, France.
Darragh DuffyDepartment of Immunology, Institut Pasteur, Paris, France.
Molly A IngersollDepartment of Immunology, Institut Pasteur, Paris, France.
Inserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex-based differences influence incidence and outcome of infectious disease. Women have a significantly greater incidence of urinary tract infection (UTI) than men, yet, conversely, male UTI is more persistent with greater associated morbidity. Mechanisms underlying these sex-based differences are unknown, in part due to a lack of experimental models. We optimized a model to transurethrally infect male mice and directly compared UTI in both sexes. Although both sexes were initially equally colonized by uropathogenic E. coli, only male and testosterone-treated female mice remained chronically infected for up to 4 weeks. Female mice had more robust innate responses, including higher IL-17 expression, and increased γδ T cells and group 3 innate lymphoid cells in the bladder following infection. Accordingly, neutralizing IL-17 abolished resolution in female mice, identifying a cytokine pathway necessary for bacterial clearance. Our findings support the concept that sex-based responses to UTI contribute to impaired innate immunity in males and provide a rationale for non-antibiotic-based immune targeting to improve the response to UTI.

Indexed as

Sex CharacteristicsAnimalsCytokinesDisease Models, AnimalDNA-Binding ProteinsEscherichia coli InfectionsFemaleImmunity, InnateInterleukin-17LymphocytesMaleMiceMice, Inbred C57BLMice, KnockoutPyelonephritisTestosteroneCytokinesDNA-Binding ProteinsIl17a protein, mouseInterleukin-17Rag2 protein, mouseTestosteroneImmunologyInfectious diseaseInnate immunitySex hormonesUTI/pyelonephritis

Identifiers

PMID31145099
PMCPMC6629110
OpenAlexW2947060322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.